NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
$323.8M
N/A
$170.8M
N/A
($457.8M)
Net Debt to FCF - (2.0x)
$229.2M
70.8% margin
PTGX Income Statement
PTGX Income Statement Overview
Crunching data... Almost there!
PTGX Income statement key metrics
Crunching data... Almost there!
PTGX Balance Sheet
PTGX Balance Sheet Overview
Crunching data... Almost there!
PTGX Balance Sheet Metrics
Crunching data... Almost there!
PTGX Cash Flow Statement
PTGX Cash Flow Statement Overview
Crunching data... Almost there!
PTGX Cash Flow Statement key metrics
Crunching data... Almost there!
PTGX Financials
Crunching data... Almost there!
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) revenue?
The Protagonist Therapeutics, Inc. (PTGX) revenue is $60.0M, reflecting a year-over-year (YoY) growth of +125.7% YoY.
What is the Protagonist Therapeutics, Inc. (PTGX) Net Income?
The Protagonist Therapeutics, Inc. (PTGX) Net Income is ($79.0M), showcasing a YoY growth of -36.0% YoY.